Publications

  • Goldfarb, David S; Choi, Michael J. "Future directions in nephrolithiasis research [editorial]". Advances in chronic kidney disease. 2009; 16: 3 (#J0156484)
  • Goldfarb, David S. "Prospects for dietary therapy of recurrent nephrolithiasis". Advances in chronic kidney disease. 2009; 16: 21 (#J0156483)
  • Fertel BS; Nelson LS; Goldfarb DS. "The underutilization of hemodialysis in patients with salicylate poisoning". Kidney international. 2008; (#J0142408)
  • Goodman JW; Asplin JR; Goldfarb DS. "Effect of two sports drinks on urinary lithogenicity". Urological research. 2008; 37: 41 (#J0156005)
  • Jamison, RL; Guarino, PD; Goldfarb, DS; Warren, SR. "Homocysteine lowering and severe kidney disease - Reply". JAMA. 2008; 299: 288 (#J0133103)
  • Keenan, RT; O'Brien, WR; Crittenden, DB; Goldfarb, DS; Pillinger, MH. "Gout Management in a Primary Care Setting: Evidence for Possible Suboptimal Treatment [Abstract]". Arthritis & rheumatism. 2008; 58: 3983 (#J0156569)
  • Leaf DE; Goldfarb DS. "Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia". Kidney international. 2008; 75: 15 (#J0145350)
  • Mattoo, Aditya; Goldfarb, David S. "Cystinuria". Seminars in nephrology. 2008; 28: 181 (#J0134477)
  • Obligado SH; Goldfarb DS. "The Association of Nephrolithiasis With Hypertension and Obesity: A Review". American journal of hypertension. 2008; 21: 257 (#J0133009)
  • O'Brien, WR; Keenan, RT; Crittenden, DB; Goldfarb, DS; Pillinger, MH. "Prevalence of Co-morbidities and Relative Contraindications to Standard Therapies in a Cohort of Gout Patients [Abstract]". Arthritis & rheumatism. 2008; 58: 4012 (#J0156570)
  • Pizzi, Laura T; Bunz, Thomas J; Coyne, Daniel W; Goldfarb, David S; Singh, Ajay K. "Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation". Kidney international. 2008; 74: 1588 (#J0155737)
  • Goldfarb, David S; Modersitzki, Frank; Asplin, John R. "A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria". Clinical journal of the American Society of Nephrology : CJASN.. 2007; 2: 745 (#J0129081)
  • Huen, Sarah C; Goldfarb, David S. "Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis". Journal of urology. 2007; 177: 1238 (#J0125072)
  • Jamison, Rex L; Hartigan, Pamela; Kaufman, James S; Goldfarb, David S; Warren, Stuart R; Guarino, Peter D; Gaziano, J Michael. "Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial". JAMA. 2007; 298: 1163 (#J0129423)
  • Maw, Anna M; Megibow, Alec J; Grasso, Michael; Goldfarb, David S. "Diagnosis of medullary sponge kidney by computed tomographic urography". American journal of kidney diseases. 2007; 50: 146 (#J0127360)
  • Bini, Edmund J; Kinkhabwala, Aditi; Goldfarb, David S. "Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens". American journal of kidney diseases. 2006; 48: 580 (#J0120517)
  • Finkielstein VA; Goldfarb DS. "Strategies for preventing calcium oxalate stones". CMAJ (Canadian Medical Association Journal). 2006; 174: 1407 (#J0114470)
  • Goldfarb, David S; Matalon, Daniel. "Principles and techniques applied to enhance elimination" IN: Goldfrank's toxicologic emergencies New York : McGraw-Hill, 2006. 2006; 160 (#C0002467)
  • Goldfarb, David S. "The sorcerer's stone". Pharos of Alpha Omega Alpha Honor Medical Society. 2006; 69: 36 (#J0122273)
  • Goldfarb, DS; Coe, FL; Asplin, JR. "Urinary cystine excretion and capacity in patients with cystinuria". Kidney international. 2006; 69: 1041 (#J0113284)
  • Goodman, Jeffrey W; Goldfarb, David S. "The role of continuous renal replacement therapy in the treatment of poisoning". Seminars in dialysis. 2006; 19: 402 (#J0120417)
  • Leaf DE; Goldfarb DS. "Mechanisms of Action of Acetazolamide in the Prophylaxis and Treatment of Acute Mountain Sickness: A Review". Journal of applied physiology (Bethesda). 2006; 102: 1313 (#J0120763)
  • Pizzi, LT; Patel, NM; Maio, VM; Goldfarb, DS; Michael, B; Fuhr, JP; Goldfarb, NI. "Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia". Dialysis & transplantation. 2006; 35: 660 (#J0121772)
  • Shalkham AS; Kirrane BM; Hoffman RS; Goldfarb DS; Nelson LS. "The availability and use of charcoal hemoperfusion in the treatment of poisoned patients". American journal of kidney diseases. 2006; 48: 239 (#J0117625)
  • Wolf J; Asplin JR; Goldfarb DS. "Chitosan does not reduce post-prandial urinary oxalate excretion". Urological research. 2006; 34: 227 (#J0112705)
  • Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS. "Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria". Journal of endourology. 2005; 19: 429 (#J0088950)
  • Goldfarb DS; Coe FL. "Renal stone disease and obstruction" IN: Hospital medicine Philadelphia : Lippincott Williams & Wilkins, 2005. 2005; (#C0001330)
  • Goldfarb DS. "Re: acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers [Comment]". Journal of urology. 2005; 173: 1048 (#J0076858)
  • Goldfarb DS; Fischer ME; Keich Y; Goldberg J. "A twin study of genetic and dietary influences on nephrolithiasis: A report from the Vietnam Era Twin (VET) Registry". Kidney international. 2005; 67: 1053 (#J0076613)
  • Lieske, John C; Goldfarb, David S; De Simone, Claudio; Regnier, Cynthia. "Use of a probiotic to decrease enteric hyperoxaluria". Kidney international. 2005; 68: 1244 (#J0134478)
  • Mehandru S; Goldfarb DS. "Nephrolithiasis complicating treatment of diabetes insipidus". Urological research. 2005; 33: 244 (#J0102522)
  • Chang MA; Goldfarb DS. "Occupational risk for nephrolithiasis and bladder dysfunction in a chauffeur". Urological research. 2004; 32: 41 (#J0076820)
  • Goldfarb DS. "How life imitates baseball". Pharos of Alpha Omega Alpha Honor Medical Society. 2004; 67: 34 (#J0067276)
  • Goldfarb DS. "Hyperkalemia after the publication of RALES [Comment]". New England journal of medicine. 2004; 351: 2448 (#J0074492)
  • Goldfarb DS; Coe FL. "The medical management of stone disease" IN: Oxford textbook of clinical nephrology Oxford : Oxford Univ. Press, 2004. 2004; (#C0001331)
  • Goldfarb DS. "Microorganisms and calcium oxalate stone disease". Nephron. 2004; 98: p48 (#J0070405)
  • Goldfarb DS; Montori V; Devereaux PJ; Schuemann H; Bhandari M; Guyatt G. "Patients at the centre: In our practice, and in our use of language (multiple letters)". Evidence Based Medicine. 2004; 9: 39 (#J0071836)
  • Goldfarb DS; Saiman L. "Tuberculosis of the genitourinary tract" IN: Tuberculosis Philadelphia : Lippincott Williams & Wilkins, 2004. 2004; 550 (#C0001829)
  • Hwang MT; Goldfarb DS. "Uric acid stones following hepatic transplantation". Urological research. 2004; 32: 423 (#J0076819)
  • Jamison RL; Hartigan P; Gaziano JM; Fortmann SP; Goldfarb DS; Haroldson JA; Kaufman J; Lavori P; McCully KS; Robinson K. "Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study". Clinical trials. 2004; 1: 451 (#J0112124)
  • Martin-Holohan A; Curtis KA; Masterson P; Goldfarb DS. "Conversion of Chronic Hemodialysis Patients from Erythropoietin Alfa to Darbepoetin Alfa". Hospital pharmacy. 2004; 39: 333 (#J0068305)
  • Zhu LC; Sidhu GS; Yee HT; Cassai ND; Goldfarb DS; Wieczorek RL. "AA-type amyloidosis associated with non-Hodgkin's lymphoma: A case report". Human pathology. 2004; 35: 1041 (#J0068303)
  • Finkielstein, V; Goldfarb, DS; Nadkarni, V; Huang, A; Rusinek, H; Lee, VS. "Single kidney glomerular filtration rate (GFR) based on dynamic contrast magnetic resonance imaging (MRI) and a multicompartmental model [Abstract]". Journal of the American Society of Nephrology. 2003; 14: 614A (#J0066852)
  • Gibney EM; Goldfarb DS. "The association of nephrolithiasis with cystic fibrosis". American journal of kidney diseases. 2003; 42: 1 (#J0050121)
  • Goldfarb DS. "Increasing prevalence of kidney stones in the United States [Comment]". Kidney international. 2003; 63: 1951 (#J0050122)
  • Henner, DE; Goldfarb, DS. "Plasma vs. serum potassium concentrations and prevalence of true hyperkalemia in hemodialysis (HD) patients [Abstract]". Journal of the American Society of Nephrology. 2003; 14: 229A (#J0067091)
  • Kaufman JS; O'Connor TZ; Zhang JH; Cronin RE; Fiore LD; Ganz MB; Goldfarb DS; Peduzzi PN. "Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis". Journal of the American Society of Nephrology. 2003; 14: 2313 (#J0051857)
  • Xuan BH; Thi TX; Nguyen ST; Goldfarb DS; Stokes MB; Rabenou RA. "Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam". American journal of kidney diseases. 2003; 41: 220 (#J0047089)
  • Goldfarb DS; Chung S. "The absence of rhabdomyolysis-induced renal failure following the World Trade Center collapse [Letter]". American journal of medicine. 2002; 113: 260 (#J0044364)
  • Goldfarb, David S. "Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date?". Reviews in urology. 2002; 4: 53 (#J0121258)
  • Goldfarb DS; Asplin JR. "Effect of grapefruit juice on urinary lithogenicity". Journal of urology. 2001; 166: 263 (#J0029012)
  • Kaufman JS; Reda DJ; Fye CL; Goldfarb DS; Henderson WG; Kleinman JG; Vaamonde CA. "Diagnostic value of iron indices in hemodialysis patients receiving epoetin". Kidney international. 2001; 60: 300 (#J0044365)
  • Charytan, D; Goldfarb, DS. "Indications for hospitalization of patients with hyperkalemia". Archives of internal medicine. 2000; 160: 1605 (#J0098249)
  • Goldfarb DS; Sly WS; Waheed A; Charney AN. "Acid-base effects on electrolyte transport in CA II-deficient mouse colon". American journal of physiology. Gastrointestinal & liver physiology. 2000; 278: G409 (#J0009098)
  • Goldfarb DS. "Cystinuria" IN: Nature encyclopedia of Life Sciences Houndsmills UK : Nature Publishing Group, 2000. 2000; (#C0001332)
  • Nakagawa Y; Asplin JR; Goldfarb DS; Parks JH; Coe FL. "Clinical use of cystine supersaturation measurements". Journal of urology. 2000; 164: 1481 (#J0044366)
  • Goldfarb DS; Coe FL. "Beverages, diet, and prevention of kidney stones". American journal of kidney diseases. 1999; 33: 398 (#J0002406)
  • Goldfarb DS. "Fomepizole for ethylene-glycol poisoning [Comment]". Lancet. 1999; 354: 1646 (#J0044368)
  • Goldfarb DS; Coe FL. "Prevention of recurrent nephrolithiasis". American family physician. 1999; 60: 2269 (#J0044367)
  • Lingeman J; Kahnoski R; Mardis H; Goldfarb DS; Grasso M; Lacy S; Scheinman SJ; Asplin JR; Parks JH; Coe FL. "Divergence between stone composition and urine supersaturation: clinical and laboratory implications". Journal of urology. 1999; 161: 1077 (#J0002481)
  • Asplin, J; Parks, J; Lingeman, J; Kahnoski, R; Mardis, H; Lacey, S; Goldfarb, D; Grasso, M; Coe, F. "Supersaturation and stone composition in a network of dispersed treatment sites". Journal of urology. 1998; 159: 1821 (#J0094449)
  • Goldfarb DS; Coe FL. "Foscarnet crystal deposition and renal failure [Comment]". American journal of kidney diseases. 1998; 32: 519 (#J0044370)
  • Goldfarb DS; Parks JH; Coe FL. "Renal stone disease in older adults". Clinics in geriatric medicine. 1998; 14: 367 (#J0044372)
  • Kaufman JS; Reda DJ; Fye CL; Goldfarb DS; Henderson WG; Kleinman JG; Vaamonde CA. "Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients". New England journal of medicine. 1998; 339: 578 (#J0044371)
  • Lazowski P; Goldfarb DS. "Images in clinical medicine. Calcified mass in a patient on long-term hemodialysis". New England journal of medicine. 1998; 338: 1427 (#J0044373)
  • Lingeman J; Mardis H; Kahnoski R; Goldfarb DS; Lacy S; Grasso M; Scheinman SJ; Parks JH; Asplin JR; Coe FL. "Medical reduction of stone risk in a network of treatment centers compared to a research clinic". Journal of urology. 1998; 160: 1629 (#J0044369)
  • Stokes MB; Chawla H; Brody RI; Kumar A; Gertner R; Goldfarb DS; Gallo G. "Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus". American journal of kidney diseases. 1997; 29: 514 (#J0009967)
  • Goldfarb, David S; Saiman, Lisa. "Tuberculosis of the genitourinary tract" IN: Tuberculosis Boston : Little Brown, 1996. 1996; (#C0002782)
  • Lazowski, P; Katz, LA; Simberkoff, MS; Goldfarb, DS. "Comparison of intradermal and intramuscular vaccination for hepatitis B in dialysis patients [Abstract]". Journal of the American Society of Nephrology. 1996; 7: A1201 (#J0092374)
  • STOKES, MB; CHAWLA, H; GERTNER, R; BRODY, RI; GOLDFARB, D; GALLO, G. "GLOMERULAR-DISEASE IN HIV-INFECTED PATIENTS WITH HEPATITIS-C VIRUS (HCV) COINFECTION [Abstract]". Journal of the American Society of Nephrology. 1995; 6: 433 (#J0149012)
  • Charney AN; Goldfarb DS; Egnor RW. "Effects of pH and cyclic adenosine monophosphate on ileal electrolyte transport in the rat and rabbit". Gastroenterology. 1991; 100: 410 (#J0044375)
  • Goldfarb DS; Chan AJ; Hernandez D; Charney AN. "Effect of thiazides on colonic NaCl absorption: role of carbonic anhydrase". American journal of physiology. 1991; 261: F452 (#J0044374)
  • Goldfarb DS; Egnor RW; Charney AN. "Effects of acid-base variables on ion transport in rat colon". Journal of clinical investigation. 1988; 81: 1903 (#J0044376)
  • Goldfarb DS; Ingrassia PM; Charney AN. "Effect of systemic acid-base balance on ileal secretion". American journal of physiology. 1987; 253: G330 (#J0044377)
  • Goldfarb, DS; Charney, AN. "ACIDOSIS REVERSES CHOLERA TOXIN-INDUCED ILEAL SECRETION [Abstract]". Clinical research. 1986; 34: A649 (#J0040095)

All data from NYU School of Medicine Ehrman Medical Library Faculty Bibliography

NYU Faculty may edit their publications and access other personalized services at http://myinfo.med.nyu.edu

For more information contact: facbib@library.med.nyu.edu
or see: http://library.med.nyu.edu/library/eresources/faculty/bib-faq.html